This brand name is authorized in Brazil, Canada, Hong Kong, Ireland, Japan, Malta, Mexico, New Zealand, Singapore, United Kingdom, United States
The drug PREMARIN contains one active pharmaceutical ingredient (API):
1
Estrogens, conjugated
UNII IU5QR144QX - ESTROGENS, CONJUGATED
|
The active ingredients of conjugated estrogens are primarily the sulfate esters of estrone, equilin sulfates, 17α-estradiol and 17β-estradiol. These substitute for the loss of estrogen production in menopausal women, and alleviate menopausal symptoms. Estrogens prevent bone loss following menopause or ovariectomy. |
Below package inserts are available for further reading:
Title | Information Source | Document Type | |
---|---|---|---|
PREMARIN Coated tablet | Medicines & Healthcare Products Regulatory Agency (GB) | MPI, EU: SmPC | |
PREMARIN Powder for solution for injection | FDA, National Drug Code (US) | MPI, US: SPL/Old | |
PREMARIN Film-coated tablet | FDA, National Drug Code (US) | MPI, US: SPL/PLR | |
PREMARIN Vaginal cream | FDA, National Drug Code (US) | MPI, US: SPL/PLR |
This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:
ATC code | Group title | Classification |
---|---|---|
G03CA57 | Conjugated estrogens | G Genito urinary system and sex hormones → G03 Sex hormones and modulators of the genital system → G03C Estrogens → G03CA Natural and semisynthetic estrogens, plain |
This drug has been assigned below unique identifiers within the countries it is being marketed:
Country | Identification scheme | Identifier(s) |
---|---|---|
Country: BR | Câmara de Regulação do Mercado de Medicamentos | Identifier(s): 522719120082407, 522719120082507 |
Country: CA | Health Products and Food Branch | Identifier(s): 02043386, 02043440, 02414678, 02414686, 02414694 |
Country: GB | Medicines & Healthcare Products Regulatory Agency | Identifier(s): 114769, 26873, 26881, 336714 |
Country: HK | Department of Health Drug Office | Identifier(s): 29753, 29754, 29755, 29759 |
Country: IE | Health Products Regulatory Authority | Identifier(s): 62063, 62071 |
Country: JP | 医薬品医療機器総合機構 | Identifier(s): 2479004F1033 |
Country: MT | Medicines Authority | Identifier(s): AA565/22704 |
Country: MX | Comisión Federal para la Protección contra Riesgos Sanitarios | Identifier(s): 31395, 44321 |
Country: NZ | Medicines and Medical Devices Safety Authority | Identifier(s): 587, 588 |
Country: SG | Health Sciences Authority | Identifier(s): 03229P, 04484P, 04706P |
Country: US | FDA, National Drug Code | Identifier(s): 0046-0749, 0046-0872, 0046-1100, 0046-1101, 0046-1102, 0046-1103, 0046-1104, 50090-0167 |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.